Case File №
#VI-2026-0724
Diju Peptides Wellness and Co
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | A Great | 4 | 7.4 | 6.3 | 8.0 | 25 Jul 2025 |
| Abaloparatide | X N/A | 1 | 8.4 | 8.4 | 8.4 | 7 May 2025 |
| ACE-031 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| AHK-CU | X N/A | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 |
| Alprostadil | X N/A | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 6.0 | 6.0 | 6.0 | 6 May 2025 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 |
| Bronchogen | X N/A | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 |
| Chonluten | X N/A | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 |
| CJC-1295 With DAC | X N/A | 1 | 9.0 | 9.0 | 9.0 | 2 Apr 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 6.5 | 6.5 | 6.5 | 16 Mar 2025 |
| Clomiphene (Clomid) Raw | X N/A | 1 | 10.0 | 10.0 | 10.0 | 17 Dec 2024 |
| Dianabol | X N/A | 1 | 8.2 | 8.2 | 8.2 | 7 May 2025 |
| DNP | X N/A | 1 | 6.1 | 6.1 | 6.1 | 8 Jul 2025 |
| EPO | X N/A | 1 | 8.2 | 8.2 | 8.2 | 20 Jun 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 8 Jul 2025 |
| GHRP-6 Acetate | X N/A | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| IGF-1 LR3 | X N/A | 1 | 9.5 | 9.5 | 9.5 | 28 Mar 2025 |
| Ivermectin | X N/A | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 |
| LGD-4033 (Ligandrol) Raw | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Liraglutide | X N/A | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 |
| MGF | X N/A | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 7.4 | 7.4 | 7.4 | 24 Apr 2025 |
| Oxytocin Acetate | X N/A | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 |
| P21 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 6 May 2025 |
| PEG MGF | X N/A | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| Prednisone | X N/A | 1 | 4.9 | 4.9 | 4.9 | 25 Apr 2025 |
| Primobolan E | X N/A | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| Semax | X N/A | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 9.9 | 9.9 | 9.9 | 20 Jun 2025 |
| SNAP-8 | X N/A | 1 | 4.4 | 4.4 | 4.4 | 27 Feb 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 8.3 | 8.3 | 8.3 | 27 Feb 2025 |
| Sustanon 400 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 |
| T3 (Liothyronine) | X N/A | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Turinabol | X N/A | 1 | 5.7 | 5.7 | 5.7 | 3 Jul 2025 |
Exhibit II
Evidence Log
44 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Abaloparatide | 7.1 A | 5mg | 6.2mg | +23.7% | 97.58% | f2yx2p | Lab A | Public |
| 25 May 2026 | AHK-CU | 9.7 A | 20mg | 21.0mg | +5.2% | 95.76% | vkv8ga | Lab D | Public |
| 25 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.0 A | 10mg | 9.2mg | -8.4% | 97.17% | 3ut6vd | Lab C | Public |
| 25 May 2026 | PEG MGF | 6.4 A | 10mg | 11.8mg | +18.4% | 99.22% | 9q4x3d | Lab C | Public |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 7.6 A | 5mg | 4.3mg | -14.5% | 98.56% | jibdx0 | Lab B | Public |
| 24 May 2026 | Prednisone | 5.9 B | 50mg | 43.3mg | -13.4% | 95.55% | gpz2yp | Lab D | Public |
| 24 May 2026 | Alprostadil | 4.3 C | 10mg | 10.2mg | +2.4% | 98.24% | ijzfz5 | Lab D | Public |
| 24 May 2026 | CJC-1295 With DAC | 10.0 A | 50mg | 43.5mg | -13.0% | 95.01% | zd4qpm | Lab F | Community |
| 24 May 2026 | SNAP-8 | 4.0 C | 20mg | 24.8mg | +24.0% | 99.84% | 91g26g | Lab E | Community |
| 23 May 2026 | P21 | 7.8 A | 15mg | 15.0mg | -0.0% | 96.43% | qci6m8 | Lab A | Community |
| 23 May 2026 | SS-31 (Elamipretide) Raw | 10.0 A | 500g | 497.7g | -0.5% | 96.45% | qgkozs | Lab E | Public |
| 23 May 2026 | Bronchogen | 7.7 A | 20mg | 24.7mg | +23.7% | 96.38% | 0gg0xb | Lab D | Public |
| 21 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 10.0 A | 25mg | 29.1mg | +16.5% | 95.39% | 8lqu7x | Lab F | Public |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 5.3 B | 20mg | 18.5mg | -7.7% | 97.08% | d3s2sn | Lab B | Public |
| 21 May 2026 | Turinabol | 6.2 A | 50mg | 55.1mg | +10.2% | 96.51% | 69h7io | Lab B | Community |
| 21 May 2026 | Dianabol | 9.7 A | 100mg | 122.9mg | +22.9% | 95.40% | 9fqa3p | Lab A | Public |
| 20 May 2026 | Sustanon 400 | 6.6 A | 100mg/ml | 122.3mg/ml | +22.3% | 97.16% | qmu1px | Lab C | Community |
| 19 May 2026 | Clomiphene (Clomid) Raw | 9.7 A | 10g | 11.9g | +18.9% | 96.63% | j25ew2 | Lab C | Public |
| 19 May 2026 | GHRP-6 Acetate | 7.6 A | 30mg | 31.4mg | +4.6% | 99.54% | 8kiaqp | Lab A | Community |
| 19 May 2026 | T3 (Liothyronine) | 6.7 A | 25mg | 28.9mg | +15.8% | 96.33% | 0ktovx | Lab D | Public |
| 29 Jan 2026 | Semax | 7.3 A | 2mg | 2.4mg | +17.6% | 95.47% | wfee3w | Lab D | Community |
| 19 Jan 2026 | Liraglutide | 8.2 A | 30mg | 32.9mg | +9.8% | 97.85% | yvunyk | Lab C | Community |
| 19 Jan 2026 | Primobolan E | 7.6 A | 250mg/ml | 217.2mg/ml | -13.1% | 98.19% | 250l8h | Lab A | Public |
| 9 Jan 2026 | Equipoise (Boldenone Undecylenate) | 4.4 C | 200mg/ml | 247.2mg/ml | +23.6% | 99.03% | ggtv7s | Lab C | Community |
| 9 Jan 2026 | MGF | 7.7 A | 20mg | 20.8mg | +3.8% | 98.68% | r0u5fz | Lab D | Public |
| 7 Jan 2026 | LGD-4033 (Ligandrol) Raw | 5.0 B | 1g | 0.9g | -5.9% | 96.99% | qgglfz | Lab D | Public |
| 6 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 8.7 A | 10g | 8.9g | -11.3% | 95.47% | d7bxr1 | Lab G | Public |
| 12 Dec 2025 | DNP | 5.0 B | 25mg | 26.7mg | +6.7% | 96.53% | 4hpcai | Lab F | Community |
| 5 Dec 2025 | Ivermectin | 4.4 C | 25mg | 29.2mg | +16.7% | 99.12% | mbnej5 | Lab F | Public |
| 17 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 6.9 A | 2mg | 1.8mg | -9.6% | 96.29% | sk7q6d | Lab E | Community |
| 5 Nov 2025 | ACE-031 | 8.4 A | 10mg | 8.8mg | -11.9% | 97.78% | kronmx | Lab G | Community |
| 5 Nov 2025 | Chonluten | 9.1 A | 20mg | 19.7mg | -1.7% | 97.44% | ofz269 | Lab D | Public |
| 5 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 A | 2mg | 1.8mg | -11.0% | 96.28% | 80zs5y | Lab F | Public |
| 4 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.4 A | 50mg | 57.5mg | +15.0% | 95.43% | mx0keo | Lab C | Public |
| 4 Nov 2025 | IGF-1 LR3 | 9.1 A | 15mg | 17.1mg | +14.2% | 98.96% | 1a3qy1 | Lab B | Public |
| 17 Oct 2025 | Tirzepatide | 7.4 A | 30mg | 32mg | +6.7% | 99.95% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | Tirzepatide | 7.9 A | 10mg | 9.87mg | -1.3% | 99.86% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | EPO | 10.0 A | 20mg | 24.8mg | +23.9% | 95.90% | serl0n | Lab F | Community |
| 9 Oct 2025 | BMK ethyl glycidate CAS 41232-97-7 | 6.6 A | 100g | 88.0g | -12.0% | 97.85% | lg4jmu | Lab A | Public |
| 3 Oct 2025 | Botulinum toxin | 8.9 A | 20mg | 18.6mg | -7.1% | 95.94% | 3qo9qz | Lab E | Public |
| 3 Oct 2025 | Oxytocin Acetate | 6.5 A | 10mg | 10.4mg | +4.3% | 96.79% | juio9m | Lab A | Community |
| 3 Oct 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 9.9 A | 100mg | 93.8mg | -6.2% | 97.67% | rqf1ws | Lab D | Community |
| 25 Jul 2025 | Tirzepatide | 8.0 A | 30mg | 30.2mg | +0.7% | 99.95% | (no batch ID) | Lab E | Public |
| 25 Jul 2025 | Tirzepatide | 6.3 B | 30mg | 28.1mg | -6.3% | 99.36% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —